Streamline Health Solutions Inc (STRM, Financial) is set to release its Q2 2024 earnings on Sep 12, 2024. The consensus estimate for Q2 2024 revenue is $4.34 million, and the earnings are expected to come in at -$0.04 per share. The full year 2024's revenue is expected to be $20.01 million and the earnings are expected to be -$0.13 per share. More detailed estimate data can be found on the Estimates page.
Streamline Health Solutions Inc (STRM, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Streamline Health Solutions Inc (STRM) for the full year 2024 have slightly increased from $19.99 million to $20.01 million. However, the estimates for 2025 have slightly declined from $20.83 million to $20.82 million. Earnings estimates for the full year 2024 have decreased from -$0.11 per share to -$0.13 per share, and for 2025, the estimates have worsened from -$0.06 per share to -$0.11 per share.
Streamline Health Solutions Inc (STRM, Financial) Reported History
In the previous quarter of 2024-04-30, Streamline Health Solutions Inc's (STRM) actual revenue was $4.33 million, which beat analysts' revenue expectations of $4.312 million by 0.42%. Streamline Health Solutions Inc's (STRM) actual earnings were -$0.05 per share, which missed analysts' earnings expectations of -$0.04 per share by 25%. After releasing the results, Streamline Health Solutions Inc (STRM) was flat in one day.
Streamline Health Solutions Inc (STRM, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 1 analyst, the average target price for Streamline Health Solutions Inc (STRM) is $1.50 with a high estimate of $1.50 and a low estimate of $1.50. The average target implies an upside of 233.33% from the current price of $0.45.
Based on GuruFocus estimates, the estimated GF Value for Streamline Health Solutions Inc (STRM, Financial) in one year is $1.17, suggesting an upside of 160% from the current price of $0.45.
Based on the consensus recommendation from 1 brokerage firm, Streamline Health Solutions Inc's (STRM, Financial) average brokerage recommendation is currently 2.0, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
